Patents by Inventor Andre Uzan

Andre Uzan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel therapeutic use of low molecular weight heparins
    Publication number: 20060100175
    Abstract: The invention concerns the use of low molecular weight heparin for preventing and/or treating motor neuron diseases.
    Type: Application
    Filed: December 21, 2005
    Publication date: May 11, 2006
    Applicant: Aventis Pharma S.A.
    Inventors: Jean-Marie Stutzmann, Andre Uzan
  • Therapeutic application of enoxaparin
    Publication number: 20050164985
    Abstract: The present invention relates to the use of enoxaparin for treating a disease linked to the modulation of heparanase activity.
    Type: Application
    Filed: December 3, 2004
    Publication date: July 28, 2005
    Applicant: Aventis Pharma S.A.
    Inventors: Andre Uzan, Umesh Shukla, Rita Samuel, Luis Toro-Figueroa
  • Novel therapeutic application of enoxaparin
    Publication number: 20040214796
    Abstract: The present invention relates to the use of enoxaparin for reducing cerebral lesion size in the treatment of cerebral ischemia.
    Type: Application
    Filed: May 19, 2004
    Publication date: October 28, 2004
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Veronique Mary, Jean-Marie Stutzmann, Andre Uzan, Florence Wahl
  • Novel therapeutic use of low molecular weight heparins
    Publication number: 20040038938
    Abstract: The invention concerns the use of low molecular weight heparin for preventing and/or treating motor neuron diseases.
    Type: Application
    Filed: August 20, 2003
    Publication date: February 26, 2004
    Applicant: AVENTIS PHARMA SA
    Inventors: Jean-Marie Stutzmann, Andre Uzan
  • Novel therapeutic use of low molecular weight heparins
    Publication number: 20030236222
    Abstract: The invention concerns the use of low molecular weight heparin for preventing and/or treating motor neuron diseases.
    Type: Application
    Filed: August 20, 2003
    Publication date: December 25, 2003
    Applicant: AVENTIS PHARMA SA
    Inventors: Jean-Marie Stutzmann, Andre Uzan
  • Use of low-molecular-weight heparins for the prevention and treatment of cerebral edemas
    Patent number: 6579858
    Abstract: Cerebral edema is prevented and treated by administering an effective amount of a low molecular weight heparin.
    Type: Grant
    Filed: November 29, 1999
    Date of Patent: June 17, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Véronique Mary, Jérémy Pratt, Jean-Marie Stutzman, André Uzan, Florence Wahl
  • Use of low-molecular-weight heparins for the prevention and treatment of trauma of the central nervous system
    Patent number: 6380173
    Abstract: Trauma of the central nervous system is prevented and treated by administering an effective amount of a low molecular weight heparin.
    Type: Grant
    Filed: November 24, 1999
    Date of Patent: April 30, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Marie Stutzmann, André Uzan, Florence Wahl
  • Novel therapeutic use of low molecular weight heparins
    Publication number: 20020040013
    Abstract: The invention concerns the use of low molecular weight heparin for preventing and/or treating motor neuron diseases.
    Type: Application
    Filed: June 14, 2001
    Publication date: April 4, 2002
    Inventors: Jean-Marie Stutzmann, Andre Uzan
  • Pharmaceutical composition comprising a compound having anti-xa activity and a platelet aggregation antagonist compound
    Publication number: 20020032214
    Abstract: The invention is also directed to pharmaceutical composition comprising a compound having anti-Xa activity, a platelet aggregation antagonist compound and a pharmaceutically acceptable carrier. The invention is also directed to a method of treating or preventing a thrombogenic condition associated with a thrombosis related ischemic disorder in a patient comprising administering to said patient pharmaceutically effective amounts of a compound having anti-Xa activity and a platelet aggregation antagonist compound. In addition, this invention is directed to the use of pharmaceutically effective amounts of a compound having anti-Xa activity and a platelet aggregation antagonist compound in the preparation of a medicament for treating or preventing a physiological condition associated with thrombosis related ischemic disorder.
    Type: Application
    Filed: March 1, 2000
    Publication date: March 14, 2002
    Inventors: Andre Uzan, Alain H Curaudeau, Robert J Leadley, Christopher T Dunwiddie, Mark H Perrone
  • Novel therapeutic application of enoxaparin
    Publication number: 20010041686
    Abstract: The present invention relates to the use of enoxaparin for the treatment of cerebral ischemia.
    Type: Application
    Filed: January 2, 2001
    Publication date: November 15, 2001
    Inventors: Veronique Mary, Jean-Marie Stutzmann, Andre Uzan, Florence Wahl
  • Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound
    Patent number: 6103705
    Abstract: The invention is also directed to pharmaceutical composition comprising a compound having anti-Xa activity, a platelet aggregation antagonist compound and a pharmaceutically acceptable carrier. The invention is also directed to a method of treating or preventing a thrombogenic condition associated with a thrombosis related ischemic disorder in a patient comprising administering to said patient pharmaceutically effective amounts of a compound having anti-Xa activity and a platelet aggregation antagonist compound. In addition, this invention is directed to the use of pharmaceutically effective amounts of a compound having anti-Xa activity and a platelet aggregation antagonist compound in the preparation of a medicament for treating or preventing a physiological condition associated with thrombosis related ischemic disorder.
    Type: Grant
    Filed: November 16, 1998
    Date of Patent: August 15, 2000
    Assignee: Aventis Pharmaceuticals Products Inc.
    Inventors: Andre Uzan, Alain H. Curaudeau, Robert J. Leadley, Christopher T. Dunwiddie, Mark H. Perrone
  • Sulfated polysaccharides obtained from heparin, preparation process, pharmaceutical composition and use thereof
    Patent number: 5849721
    Abstract: This invention relates to mixtures of sulfated oligosaccharides which possess antithrombotic properties and are useful for the treatment and prevention of venous and arterial thrombosis, prevention of arterial thrombotic accidents, and in the prevention of thrombosis in surgical equipment, to pharmaceutical compositions including such mixtures, to processes for preparing such mixtures, and to the use of such mixtures in the prevention of thrombosis in surgical equipment.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 15, 1998
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventor: Andre Uzan
  • Preparation of sulfated polysaccharides for treatment or prevention of thromboses
    Patent number: 5721357
    Abstract: The invention relates to new mixtures of sulfated oligosaccharides having the general structure of heparin constitutive oligosaccharides, having an average molecular mass of 6.+-.0.6 kD, a polydispersiveness close to 1 and the capacity of inhibiting the production of thrombin. The invention also relates to their preparation and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: May 1, 1996
    Date of Patent: February 24, 1998
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Jean-Pierre Baron, Andre Brun, Hendrik Hemker, Andre Uzan
  • Sulfated polysaccharids for treatment or prevention of thromboses
    Patent number: 5707973
    Abstract: The invention relates to new mixtures of sulfated oligosaccharides having the general structure of heparin constitutive oligosaccharides, having an average molecular mass of 6.+-.0.6 kD, a polydispersiveness close to 1 and the capacity of inhibiting the production of thrombin. The invention also relates to their preparation and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: December 9, 1994
    Date of Patent: January 13, 1998
    Assignee: Rhone-Poulenc Rorer S.A.
    Inventors: Jean-Pierre Baron, Andre Brun, Hendrik Hemker, Andre Uzan